humble beginnings

Global supply chain solution company to bring plant to Houston area

Renewable Parts, an independent supply chain solutions for the wind industry that works with remanufactured and refurbished products, announced that its North American operations will be based in Humble. Photo courtesy of Renewable Parts

A Scottish company has chosen a Houston suburb as its home for North American operations.

Renewable Parts, an independent supply chain solutions for the wind industry that works with remanufactured and refurbished products, announced that its North American operations will be based in Humble. The new office will host the parts recirculation workshop to service the North American market.

"Being close to Houston was important for us as a business. Texas has a thriving wind industry and an abundance of turbines that we have vast experience on," CEO Michael Forbes says in a news release, "And Houston is widely considered the Energy Capital of the World — a great opportunity for us to find good people and collaborate with some of the many great business that are located there.

"We were also helped through the process of establishing our new venture by the Greater Houston Partnership, who gave us a warm welcome and connected us with many of the people who have gone on to play a part in the business set-up, from finding a location to supporting us with the legal side of things," he continues.

For over a decade, Renewable Parts successfully has been recirculating wind turbine component parts at scale for service providers, turbine operators and even turbine OEMs.

Craig Rhodes, senior vice president of economic development for the Greater Houston Partnership hopes the new location will help boost the local economy.

"Renewable Parts' decision to establish their North American operations in Humble, Texas, is further testament to the Houston region's strong infrastructure, skilled workforce and unmatched industry expertise,” Rhodes says in the release.

Trending News

A View From HETI

Cemvita has named a new leader in Brazil. Photo via cemvita.com

Houston industrial biotech company Cemvita has announced two strategic moves to advance its operations in Brazil.

The company, which utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals, acquired a complementary technology that expands its IP and execution of scale-up capacity, according to a news release. The acquisition will bring additional synthetic biology toolsets that Cemvita believes will assist with compressing and commercializing timelines.

The company also appointed Luciano Zamberlan as vice president of operations based in Brazil.

Zamberlan will lead operational execution, site readiness and early commissioning activities in Brazil. He brings more than 20 years of experience in biotechnology to the role. He recently served as director of engineering at Raízen, Brazil’s largest ethanol producer and the world’s largest producer of sugarcane ethanol. At Raízen, he coordinated the implementation of four greenfield plants and oversaw operational teams and process optimization for second-generation ethanol (E2G) and biogas.

“I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources,” Zamberlan said in the release. “My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future.”

Cemvita expanded to Brazil in January to help capitalize on the country’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, enacted in 2024. The law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

“These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms,” Marcio Silva, CTO of Cemvita, said in the news release. “Together, they strengthen our ability to move from proof-of-concept to industrial reality.”

Trending News